Companies: 10,795·Total market cap: $144.5T
Evotec SE

Evotec SE

EVONASDAQHealthcare● Active
$2.84
+$0.04(+1.25%)
Market Cap$1.0B
P/E Ratio—
52W High$4.44
52W Low$2.31
EmployeesOwnershipInsider Trades

Evotec SE (EVO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · EVO · as of Apr 8, 2026

Latest filing snapshot

4,553
-274-5.68%vs prior year

Evotec SE (EVO) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global
Total Employees
4,553
Change (1Y)
-274
Growth % (1Y)
-5.68%
Revenue / Employee
$166.3K
Net Income / Employee
$-21.8K
Market Cap
$1.0B

EVO Employee Count

2007 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-04-084,553-274-5.68%
2025-04-174,827-333-6.45%
2024-08-145,160+208+4.20%
2023-05-124,952+754+17.96%
2022-04-264,198+4,051+2755.78%
2010-06-07147-271-64.83%
2009-06-05418+215+105.91%
2008-06-30203——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic
#SymbolCompanyEmployees
#1
Evotec SE
EVO
Evotec SEYOU
4,553#2
Azenta, Inc.
AZTA
Azenta, Inc.
3,000#3
NovoCure Limited
NVCR
NovoCure Limited
1,488#4
Alvotech
ALVO
Alvotech
1,012#5
Pacira BioSciences, Inc.
PCRX
Pacira BioSciences, Inc.
788#6
Harrow Health, Inc.
HROW
Harrow Health, Inc.
382#7
Pharvaris N.V.
PHVS
Pharvaris N.V.
108
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · EVO peer comparison

About EVO employees

EVO Employees · Headcount

Evotec SE (EVO) employee data is sourced from the annual SEC 20-F filing. As of 2025, Evotec SE had 4,553 full-time employees globally. Full-time employees only. Global consolidated headcount.

Evotec SE employs 4,553 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $166,321, reflecting the company's operational efficiency.

Evotec SE's workforce decreased by 274 (5.68%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Evotec SE's revenue per employee of $166,321 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

EVO Employees · 5 questions

As of the latest SEC 20-F filing (2025), Evotec SE had 4,553 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Evotec SE employee counthow many employees does Evotec SE haveEVO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-04-08